Host NLRP6 exacerbates graft-versus-host disease independent of gut microbial composition

[1]  B. Blazar,et al.  Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy. , 2017, The New England journal of medicine.

[2]  J. Raes,et al.  Nlrp6‐ and ASC‐Dependent Inflammasomes Do Not Shape the Commensal Gut Microbiota Composition , 2017, Immunity.

[3]  P. Schloss,et al.  NLRP6 Protects Il10-/- Mice from Colitis by Limiting Colonization of Akkermansia muciniphila. , 2017, Cell reports.

[4]  P. Reddy,et al.  Regulating Damage from Sterile Inflammation: A Tale of Two Tolerances. , 2017, Trends in immunology.

[5]  E. Elinav,et al.  NLRP6: A Multifaceted Innate Immune Sensor. , 2017, Trends in immunology.

[6]  P. Reddy,et al.  Tissue tolerance: a distinct concept to control acute GVHD severity. , 2017, Blood.

[7]  M. V. D. van den Brink,et al.  The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease. , 2017, Blood.

[8]  Y. Taur,et al.  Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice , 2016, Science Translational Medicine.

[9]  Corinne Rossi,et al.  Gut microbiome derived metabolites modulate intestinal epithelial cell damage and mitigate Graft-versus-Host Disease , 2016, Nature Immunology.

[10]  R. Jenq,et al.  Interleukin-22 Promotes Intestinal Stem Cell-Mediated Epithelial Regeneration , 2015, Nature.

[11]  Sarah L. Westcott,et al.  De novo clustering methods outperform reference-based methods for assigning 16S rRNA gene sequences to operational taxonomic units , 2015, PeerJ.

[12]  I. Amit,et al.  Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling , 2015, Cell.

[13]  D. Munn,et al.  GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells. , 2015, Blood.

[14]  M. Idzko,et al.  MicroRNA-155-deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation. , 2015, Blood.

[15]  A. Mócsai,et al.  Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage , 2014, Nature Medicine.

[16]  E. Elinav,et al.  NLRP6 Inflammasome Orchestrates the Colonic Host-Microbial Interface by Regulating Goblet Cell Mucus Secretion , 2014, Cell.

[17]  James R. Cole,et al.  Ribosomal Database Project: data and tools for high throughput rRNA analysis , 2013, Nucleic Acids Res..

[18]  Bihui Huang,et al.  Mucus Enhances Gut Homeostasis and Oral Tolerance by Delivering Immunoregulatory Signals , 2013, Science.

[19]  A. Kaser,et al.  Paneth cells as a site of origin for intestinal inflammation , 2013, Nature.

[20]  M. Idzko,et al.  The Nlrp3 inflammasome regulates acute graft-versus-host disease , 2013, The Journal of experimental medicine.

[21]  Matthias Stelzner,et al.  Isolation and characterization of intestinal stem cells based on surface marker combinations and colony-formation assay. , 2013, Gastroenterology.

[22]  Sarah L. Westcott,et al.  Development of a Dual-Index Sequencing Strategy and Curation Pipeline for Analyzing Amplicon Sequence Data on the MiSeq Illumina Sequencing Platform , 2013, Applied and Environmental Microbiology.

[23]  E. Elinav,et al.  Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer , 2013, Proceedings of the National Academy of Sciences.

[24]  K. Murphy,et al.  Host-derived CD8+ dendritic cells are required for induction of optimal graft-versus-tumor responses after experimental allogeneic bone marrow transplantation. , 2013, Blood.

[25]  K. Akashi,et al.  Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins. , 2012, Blood.

[26]  J. Bertin,et al.  NLRP6 Negatively Regulates Innate Immunity and Host Defense Against Bacterial Pathogens , 2012, Nature.

[27]  R. Khanin,et al.  Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation , 2012, The Journal of experimental medicine.

[28]  R. Korngold,et al.  Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen-presenting cells. , 2012, Blood.

[29]  I. Maillard,et al.  Ikaros-Notch axis in host hematopoietic cells regulates experimental graft-versus-host disease. , 2011, Blood.

[30]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[31]  J. Bertin,et al.  A Functional Role for Nlrp6 in Intestinal Inflammation and Tumorigenesis , 2011, The Journal of Immunology.

[32]  Richard A. Flavell,et al.  NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis , 2011, Cell.

[33]  M. Chamaillard,et al.  Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury , 2011, Proceedings of the National Academy of Sciences.

[34]  B. B. Finlay,et al.  Roadblocks in the gut: barriers to enteric infection , 2011, Cellular microbiology.

[35]  Patrick D. Schloss,et al.  Assessing and Improving Methods Used in Operational Taxonomic Unit-Based Approaches for 16S rRNA Gene Sequence Analysis , 2011, Applied and Environmental Microbiology.

[36]  Lena Holm,et al.  Bacteria Penetrate the Inner Mucus Layer before Inflammation in the Dextran Sulfate Colitis Model , 2010, PloS one.

[37]  E. Thiel,et al.  MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease , 2010, Gut.

[38]  P. Schloss.  A High-Throughput DNA Sequence Aligner for Microbial Ecology Studies , 2009, PloS one.

[39]  Martin Hartmann,et al.  Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities , 2009, Applied and Environmental Microbiology.

[40]  M. McGuckin,et al.  MUC1 Limits Helicobacter pylori Infection both by Steric Hindrance and by Acting as a Releasable Decoy , 2009, PLoS pathogens.

[41]  C. Dinarello,et al.  Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. , 2008, The Journal of clinical investigation.

[42]  W. Ludwig,et al.  SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB , 2007, Nucleic acids research.

[43]  J. Tiedje,et al.  Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.

[44]  A. Verkman,et al.  Impaired enterocyte proliferation in aquaporin-3 deficiency in mouse models of colitis , 2007, Gut.

[45]  R. Korngold,et al.  A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses , 2005, Nature Medicine.

[46]  Jack C. Yue,et al.  A Similarity Measure Based on Species Proportions , 2005 .

[47]  Marti J. Anderson,et al.  A new method for non-parametric multivariate analysis of variance in ecology , 2001 .

[48]  J. Crawford,et al.  Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. , 1998, The Journal of clinical investigation.

[49]  J. Crawford,et al.  Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. , 1998, The Journal of clinical investigation.

[50]  E. Holler,et al.  Graft-versus-host disease , 2009, The Lancet.

[51]  K. Murphy,et al.  Host-derived CD 8 1 dendritic cells are required for induction of optimal graft-versus-tumor responses after experimental allogeneic bone marrow transplantation , 2013 .

[52]  J. Crawford,et al.  Tumor Necrosis Factor – a Production to Lipopolysaccharide Stimulation by Donor Cells Predicts the Severity of Experimental Acute Graft-Versus-Host Disease , 1998 .